In a new video, Cynthia Bens, patient advocate and Senior Vice President of Public Policy at the Personalized Medicine Coalition, shares her views on how adopting foreign price controls for prescription medicines will impact patients in the U.S.
“I wouldn’t say the President’s proposal for reference pricing is the right way to deal with drug pricing issues. We need to look at the problem holistically. …
“What’s really challenging, right now, is all of the estimates on what the president’s foreign reference pricing proposal really means for patients is that there’s going to be a reduction in research and development. …
“The harms of the foreign reference pricing proposal really outweigh the benefits that patients are going to see.”
To learn more about the flaws of importing foreign price controls, visit bio.org/save-cures.
###
